- Home
- ATXS vs ALRS Comparison
ATXS vs ALRS Comparison
Compare ATXS & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- ALRS
- Stock Information
- Founded
- ATXS 2008
- ALRS 1879
- Country
- ATXS United States
- ALRS United States
- Employees
- ATXS N/A
- ALRS N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- ALRS Major Banks
- Sector
- ATXS Health Care
- ALRS Finance
- Exchange
- ATXS Nasdaq
- ALRS Nasdaq
- Market Cap
- ATXS 516.4M
- ALRS 488.5M
- IPO Year
- ATXS 2015
- ALRS 2019
- Fundamental
- Price
- ATXS $7.50
- ALRS $19.62
- Analyst Decision
- ATXS Strong Buy
- ALRS Hold
- Analyst Count
- ATXS 5
- ALRS 4
- Target Price
- ATXS $25.60
- ALRS $23.25
- AVG Volume (30 Days)
- ATXS 368.6K
- ALRS 103.4K
- Earning Date
- ATXS 03-03-2025
- ALRS 01-31-2025
- Dividend Yield
- ATXS N/A
- ALRS 4.03%
- EPS Growth
- ATXS N/A
- ALRS N/A
- EPS
- ATXS N/A
- ALRS 0.16
- Revenue
- ATXS N/A
- ALRS $164,503,000.00
- Revenue This Year
- ATXS N/A
- ALRS N/A
- Revenue Next Year
- ATXS N/A
- ALRS $26.79
- P/E Ratio
- ATXS N/A
- ALRS $121.95
- Revenue Growth
- ATXS N/A
- ALRS N/A
- 52 Week Low
- ATXS $6.96
- ALRS $17.99
- 52 Week High
- ATXS $16.90
- ALRS $25.85
- Technical
- Relative Strength Index (RSI)
- ATXS 29.58
- ALRS 45.81
- Support Level
- ATXS $7.29
- ALRS $19.29
- Resistance Level
- ATXS $7.95
- ALRS $19.09
- Average True Range (ATR)
- ATXS 0.42
- ALRS 0.44
- MACD
- ATXS -0.08
- ALRS 0.14
- Stochastic Oscillator
- ATXS 15.25
- ALRS 88.11
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.